Loading…
A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes
Newborn screening (NBS) programmes are essential in the diagnosis of inherited metabolic diseases (IMDs) and for access to disease modifying treatment. Most European countries follow the World Health Organisation (WHO) criteria to determine which disorders are appropriate for screening at birth; how...
Saved in:
Published in: | International journal of neonatal screening 2022-03, Vol.8 (2), p.25 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3 |
---|---|
cites | cdi_FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3 |
container_end_page | |
container_issue | 2 |
container_start_page | 25 |
container_title | International journal of neonatal screening |
container_volume | 8 |
creator | Burlina, Alberto Jones, Simon A Chakrapani, Anupam Church, Heather J Heales, Simon Wu, Teresa H Y Morton, Georgina Roberts, Patricia Sluys, Erica F Cheillan, David |
description | Newborn screening (NBS) programmes are essential in the diagnosis of inherited metabolic diseases (IMDs) and for access to disease modifying treatment. Most European countries follow the World Health Organisation (WHO) criteria to determine which disorders are appropriate for screening at birth; however, these criteria are interpreted and implemented by individual countries differently, creating disparities. Advances in research and diagnostics, together with the promise of new treatments, offer new possibilities to accelerate the expansion of evidence-based screening programmes. A novel and robust algorithm was built to objectively assess and prioritise IMDs for inclusion in NBS programmes. The Wilson and Jungner classic screening principles were used as a foundation to develop individual and measurable criteria. The proposed algorithm is a point-based system structured upon three pillars: condition, screening, and treatment. The algorithm was tested by applying the six IMDs currently approved in the United Kingdom NBS programme. The algorithm generates a weight-based score that could be used as the first step in the complex process of evaluating disorders for inclusion on NBS programmes. By prioritising disorders to be further evaluated, individual countries are able to assess the economic, societal and political aspects of a potential screening programme. |
doi_str_mv | 10.3390/ijns8020025 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_db98af22eefe43c787d56700ed2973ef</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_db98af22eefe43c787d56700ed2973ef</doaj_id><sourcerecordid>2679738116</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3</originalsourceid><addsrcrecordid>eNpdkl1rFDEUhgdRbKm98l4CXupqPieTG2Fpq11YraCCdyHJnOxmmJlsk5mV_nujW8tWCCQkT56TE96qeknwO8YUfh-6MTeYYkzFk-qUcqwWgoifT4_WJ9V5zh3GmAgumWTPqxMmeF0TVZ9Wt0v0BX6h5W6XonFbNEV0YztwU9hDf4eu9qafzQRoNW4hhQla9BkmY2MfHLoMGUyGjHxMBXD9nEMcURlFaWMa0TeXAMYwbtDXFDfJDAPkF9Uzb_oM5_fzWfXj49X3i-vF-ubT6mK5Xjgu1bSQNeGENJa4xrVENY4S6z0IBRaEF6rhQlCCGzDCSGokI-Al9wrAWm9Ny86q1cHbRtPpXQqDSXc6mqD_bsS00SZNwfWgW6sa4ykF8MCZk41sRS0xhpYqycAX14eDazfbAVoH45RM_0j6-GQMW72Je60wqykXRfD2INj-d-16udZhzJAGjZkUvHS6JwV_fV8vxdsZ8qS7OKexfJemtSxvagipC_XmQLkUc07gH8wE6z_p0EfpKPSr4x4e2H9ZYL8BkE63vw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2679738116</pqid></control><display><type>article</type><title>A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Burlina, Alberto ; Jones, Simon A ; Chakrapani, Anupam ; Church, Heather J ; Heales, Simon ; Wu, Teresa H Y ; Morton, Georgina ; Roberts, Patricia ; Sluys, Erica F ; Cheillan, David</creator><creatorcontrib>Burlina, Alberto ; Jones, Simon A ; Chakrapani, Anupam ; Church, Heather J ; Heales, Simon ; Wu, Teresa H Y ; Morton, Georgina ; Roberts, Patricia ; Sluys, Erica F ; Cheillan, David</creatorcontrib><description>Newborn screening (NBS) programmes are essential in the diagnosis of inherited metabolic diseases (IMDs) and for access to disease modifying treatment. Most European countries follow the World Health Organisation (WHO) criteria to determine which disorders are appropriate for screening at birth; however, these criteria are interpreted and implemented by individual countries differently, creating disparities. Advances in research and diagnostics, together with the promise of new treatments, offer new possibilities to accelerate the expansion of evidence-based screening programmes. A novel and robust algorithm was built to objectively assess and prioritise IMDs for inclusion in NBS programmes. The Wilson and Jungner classic screening principles were used as a foundation to develop individual and measurable criteria. The proposed algorithm is a point-based system structured upon three pillars: condition, screening, and treatment. The algorithm was tested by applying the six IMDs currently approved in the United Kingdom NBS programme. The algorithm generates a weight-based score that could be used as the first step in the complex process of evaluating disorders for inclusion on NBS programmes. By prioritising disorders to be further evaluated, individual countries are able to assess the economic, societal and political aspects of a potential screening programme.</description><identifier>ISSN: 2409-515X</identifier><identifier>EISSN: 2409-515X</identifier><identifier>DOI: 10.3390/ijns8020025</identifier><identifier>PMID: 35466196</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Algorithms ; Disease ; Fatalities ; inherited disorder ; inherited metabolic disease ; Life Sciences ; Medical screening ; Metabolic disorders ; newborn screening (NBS) ; paediatrics ; Principles ; Public health ; rare diseases</subject><ispartof>International journal of neonatal screening, 2022-03, Vol.8 (2), p.25</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3</citedby><cites>FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3</cites><orcidid>0000-0001-7724-137X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2679738116/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2679738116?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,44569,53769,53771,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35466196$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-03754198$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Burlina, Alberto</creatorcontrib><creatorcontrib>Jones, Simon A</creatorcontrib><creatorcontrib>Chakrapani, Anupam</creatorcontrib><creatorcontrib>Church, Heather J</creatorcontrib><creatorcontrib>Heales, Simon</creatorcontrib><creatorcontrib>Wu, Teresa H Y</creatorcontrib><creatorcontrib>Morton, Georgina</creatorcontrib><creatorcontrib>Roberts, Patricia</creatorcontrib><creatorcontrib>Sluys, Erica F</creatorcontrib><creatorcontrib>Cheillan, David</creatorcontrib><title>A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes</title><title>International journal of neonatal screening</title><addtitle>Int J Neonatal Screen</addtitle><description>Newborn screening (NBS) programmes are essential in the diagnosis of inherited metabolic diseases (IMDs) and for access to disease modifying treatment. Most European countries follow the World Health Organisation (WHO) criteria to determine which disorders are appropriate for screening at birth; however, these criteria are interpreted and implemented by individual countries differently, creating disparities. Advances in research and diagnostics, together with the promise of new treatments, offer new possibilities to accelerate the expansion of evidence-based screening programmes. A novel and robust algorithm was built to objectively assess and prioritise IMDs for inclusion in NBS programmes. The Wilson and Jungner classic screening principles were used as a foundation to develop individual and measurable criteria. The proposed algorithm is a point-based system structured upon three pillars: condition, screening, and treatment. The algorithm was tested by applying the six IMDs currently approved in the United Kingdom NBS programme. The algorithm generates a weight-based score that could be used as the first step in the complex process of evaluating disorders for inclusion on NBS programmes. By prioritising disorders to be further evaluated, individual countries are able to assess the economic, societal and political aspects of a potential screening programme.</description><subject>Algorithms</subject><subject>Disease</subject><subject>Fatalities</subject><subject>inherited disorder</subject><subject>inherited metabolic disease</subject><subject>Life Sciences</subject><subject>Medical screening</subject><subject>Metabolic disorders</subject><subject>newborn screening (NBS)</subject><subject>paediatrics</subject><subject>Principles</subject><subject>Public health</subject><subject>rare diseases</subject><issn>2409-515X</issn><issn>2409-515X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkl1rFDEUhgdRbKm98l4CXupqPieTG2Fpq11YraCCdyHJnOxmmJlsk5mV_nujW8tWCCQkT56TE96qeknwO8YUfh-6MTeYYkzFk-qUcqwWgoifT4_WJ9V5zh3GmAgumWTPqxMmeF0TVZ9Wt0v0BX6h5W6XonFbNEV0YztwU9hDf4eu9qafzQRoNW4hhQla9BkmY2MfHLoMGUyGjHxMBXD9nEMcURlFaWMa0TeXAMYwbtDXFDfJDAPkF9Uzb_oM5_fzWfXj49X3i-vF-ubT6mK5Xjgu1bSQNeGENJa4xrVENY4S6z0IBRaEF6rhQlCCGzDCSGokI-Al9wrAWm9Ny86q1cHbRtPpXQqDSXc6mqD_bsS00SZNwfWgW6sa4ykF8MCZk41sRS0xhpYqycAX14eDazfbAVoH45RM_0j6-GQMW72Je60wqykXRfD2INj-d-16udZhzJAGjZkUvHS6JwV_fV8vxdsZ8qS7OKexfJemtSxvagipC_XmQLkUc07gH8wE6z_p0EfpKPSr4x4e2H9ZYL8BkE63vw</recordid><startdate>20220325</startdate><enddate>20220325</enddate><creator>Burlina, Alberto</creator><creator>Jones, Simon A</creator><creator>Chakrapani, Anupam</creator><creator>Church, Heather J</creator><creator>Heales, Simon</creator><creator>Wu, Teresa H Y</creator><creator>Morton, Georgina</creator><creator>Roberts, Patricia</creator><creator>Sluys, Erica F</creator><creator>Cheillan, David</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7724-137X</orcidid></search><sort><creationdate>20220325</creationdate><title>A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes</title><author>Burlina, Alberto ; Jones, Simon A ; Chakrapani, Anupam ; Church, Heather J ; Heales, Simon ; Wu, Teresa H Y ; Morton, Georgina ; Roberts, Patricia ; Sluys, Erica F ; Cheillan, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Algorithms</topic><topic>Disease</topic><topic>Fatalities</topic><topic>inherited disorder</topic><topic>inherited metabolic disease</topic><topic>Life Sciences</topic><topic>Medical screening</topic><topic>Metabolic disorders</topic><topic>newborn screening (NBS)</topic><topic>paediatrics</topic><topic>Principles</topic><topic>Public health</topic><topic>rare diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burlina, Alberto</creatorcontrib><creatorcontrib>Jones, Simon A</creatorcontrib><creatorcontrib>Chakrapani, Anupam</creatorcontrib><creatorcontrib>Church, Heather J</creatorcontrib><creatorcontrib>Heales, Simon</creatorcontrib><creatorcontrib>Wu, Teresa H Y</creatorcontrib><creatorcontrib>Morton, Georgina</creatorcontrib><creatorcontrib>Roberts, Patricia</creatorcontrib><creatorcontrib>Sluys, Erica F</creatorcontrib><creatorcontrib>Cheillan, David</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International journal of neonatal screening</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burlina, Alberto</au><au>Jones, Simon A</au><au>Chakrapani, Anupam</au><au>Church, Heather J</au><au>Heales, Simon</au><au>Wu, Teresa H Y</au><au>Morton, Georgina</au><au>Roberts, Patricia</au><au>Sluys, Erica F</au><au>Cheillan, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes</atitle><jtitle>International journal of neonatal screening</jtitle><addtitle>Int J Neonatal Screen</addtitle><date>2022-03-25</date><risdate>2022</risdate><volume>8</volume><issue>2</issue><spage>25</spage><pages>25-</pages><issn>2409-515X</issn><eissn>2409-515X</eissn><abstract>Newborn screening (NBS) programmes are essential in the diagnosis of inherited metabolic diseases (IMDs) and for access to disease modifying treatment. Most European countries follow the World Health Organisation (WHO) criteria to determine which disorders are appropriate for screening at birth; however, these criteria are interpreted and implemented by individual countries differently, creating disparities. Advances in research and diagnostics, together with the promise of new treatments, offer new possibilities to accelerate the expansion of evidence-based screening programmes. A novel and robust algorithm was built to objectively assess and prioritise IMDs for inclusion in NBS programmes. The Wilson and Jungner classic screening principles were used as a foundation to develop individual and measurable criteria. The proposed algorithm is a point-based system structured upon three pillars: condition, screening, and treatment. The algorithm was tested by applying the six IMDs currently approved in the United Kingdom NBS programme. The algorithm generates a weight-based score that could be used as the first step in the complex process of evaluating disorders for inclusion on NBS programmes. By prioritising disorders to be further evaluated, individual countries are able to assess the economic, societal and political aspects of a potential screening programme.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35466196</pmid><doi>10.3390/ijns8020025</doi><orcidid>https://orcid.org/0000-0001-7724-137X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2409-515X |
ispartof | International journal of neonatal screening, 2022-03, Vol.8 (2), p.25 |
issn | 2409-515X 2409-515X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_db98af22eefe43c787d56700ed2973ef |
source | Publicly Available Content Database; PubMed Central |
subjects | Algorithms Disease Fatalities inherited disorder inherited metabolic disease Life Sciences Medical screening Metabolic disorders newborn screening (NBS) paediatrics Principles Public health rare diseases |
title | A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T21%3A47%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20New%20Approach%20to%20Objectively%20Evaluate%20Inherited%20Metabolic%20Diseases%20for%20Inclusion%20on%20Newborn%20Screening%20Programmes&rft.jtitle=International%20journal%20of%20neonatal%20screening&rft.au=Burlina,%20Alberto&rft.date=2022-03-25&rft.volume=8&rft.issue=2&rft.spage=25&rft.pages=25-&rft.issn=2409-515X&rft.eissn=2409-515X&rft_id=info:doi/10.3390/ijns8020025&rft_dat=%3Cproquest_doaj_%3E2679738116%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2679738116&rft_id=info:pmid/35466196&rfr_iscdi=true |